Loading organizations...
Loading organizations...
Biopharmaceutical company developing treatments for sickle cell disease.
Global Blood Therapeutics has raised $88.7M across 2 funding rounds.
Global Blood Therapeutics has raised $88.7M in total across 2 funding rounds.
Global Blood Therapeutics has raised $88.7M in total across 2 funding rounds.
Global Blood Therapeutics's investors include William Slattery, Perceptive Life Sciences, RA Capital Management, Sabby Capital, Wellington Management, Charles Homcy.
Global Blood Therapeutics has raised $88.7M across 2 funding rounds. Most recently, it raised $48.0M Series B in January 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2015 | $48.0M Series B | William Slattery, Perceptive Life Sciences, RA Capital Management, Sabby Capital, Wellington Management | |
| Jun 14, 2012 | $40.7M Series A | Charles Homcy |